Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
Gastrointestinal Endoscopy|November 1, 1982
Is lumbar epidural analgesia an alternative in patients who have incomplete colonoscopy with standard premedication?H Bleiberg, T Deloof, P Ewalenko, et al.
Acta Clinica Belgica|March 21, 2008
Cost-effectiveness of cetuximab in combination with irinotecan compared with current care in metastatic colorectal cancer after failure on irinotecan--a Belgian analysisL Annemans, E Van Cutsem, Y Humblet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancerA Lacave, J Wils, H Bleiberg, et al.
Histopathology|November 1, 1982
Total parenteral nutrition-induced cholestasis mimicking large bile duct obstructionJ J Body, H Bleiberg, D Bron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patientsH Bleiberg, M Piccart, S Lips, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1989
Controversies in the management of gastrointestinal non-Hodgkin's lymphomasD Bron, R Regnier, H Bleiberg, et al.
Cancer Chemotherapy and Pharmacology|December 1, 1982
Combination of dacarbazine and mitomycin in advanced colorectal cancerH Bleiberg, M Clavel, C Nicaise, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1985
Phase II study of epirubicin in advanced adenocarcinoma of the pancreasJ Wils, H Bleiberg, G Blijham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1993
Compassionate use of tropisetron in patients at high risk of severe emesisH Bleiberg, S Van Belle, R Paridaens, et al.
Drugs|January 1, 1992
Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatmentH Bleiberg, S Van Belle, R Paridaens, et al.
Pageof 13